In 2023, Belgium led the European export of sensitising emulsions for photographic uses, accounting for the highest value among the countries listed. Despite a marginal decline of 2.52% year-on-year, it maintained the largest share. The Netherlands showed robust growth with a 6.86% increase, while Germany, France, and Italy experienced significant declines of 6.93%, 7.86%, and 6.99% respectively. Conversely, Hungary and Poland saw substantial increases, with Hungary boasting a 10.14% rise, and Poland achieving a 6.21% gain. Portugal stood out with the highest growth rate of 13.81% among smaller exporters, whereas Austria faced the steepest decline of 37.29%.
Looking forward, the European export market for sensitising emulsions is expected to continue evolving, driven by technological advancements and shifts in photographic and imaging demands. Key trends to watch include the impact of digital photography on traditional emulsion demand and increasing environmental regulations. Market dynamics may further shift as countries pursue innovation and sustainability, potentially altering traditional trade patterns.
Top countries in Export of Sensitising Emulsions for Photographic Uses by Country
| # | 10 Countries | Kilograms | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Belgium | 39,756,000 | 2023 | +0.47% | -2.52% | View data |
| 2 | 2 Netherlands | 28,520,000 | 2023 | +9.49% | +6.86% | View data |
| 3 | 3 Germany | 17,357,000 | 2023 | -6.7% | -6.93% | View data |
| 4 | 4 France | 6,433,900 | 2023 | -8.46% | -7.86% | View data |
| 5 | 5 Spain | 5,333,400 | 2023 | +3.34% | +2.38% | View data |
| 6 | 6 Italy | 4,141,700 | 2023 | -6.79% | -6.99% | View data |
| 7 | 7 Hungary | 1,975,400 | 2023 | +5% | +10.14% | View data |
| 8 | 8 Poland | 1,171,100 | 2023 | +3.84% | +6.21% | View data |
| 9 | 9 Ireland | 490,400 | 2023 | +16.52% | -4.99% | View data |
| 10 | 10 Czechia | 438,080 | 2023 |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...